Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

NCT00481767 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

676

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papillomavirus (HPV) Infection

Interventions

BIOLOGICAL: Cervarix
DRUG: Placebo Al(OH)3

Sponsor

GlaxoSmithKline